Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-347-918-3531

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Gene Synthesis Market Outlook (2023 to 2033)

The global gene synthesis market is expected to grow at a sturdy rate of 19.2% during the forecast period. In 2023, the market valuation is expected to be at US$ 779.4 million. By 2033, the estimation is projected to cross US$ 4.5 billion.

Key factors supporting the market growth are:

  • Policies set by governments related to synthetic biology, which supports artificial gene synthesis
  • Growth in life science research further reflects the development of innovative products and services
  • Increasing research and development investments to meet the growing healthcare industry's needs to combat new diseases

The ability to synthesize whole genes, metabolic pathways and even genomes has become possible in the last 30 years. Genetic engineering has evolved into a gene synthesis process that creates double-stranded DNA from oligonucleotides using different assembly methods into plasmids for transfection. The evolution has certainly assisted healthcare experts in predicting the pathogen behaviour before it becomes a serious cause of concern.

Various methods are currently used based on DNA complexity and length. The researchers are also in the process of developing a system which processes several samples automatically. To maintain the brand value, the manufacturers are laying a lot of emphasis on Intellectual Property Rights.

EVONETIX LTD has announced that a European patent has been granted for its proprietary Binary Assembly method in gene synthesis. As a result of the patent (EP 3688189 B1), Evonetix has further enhanced its IP portfolio and enabled a new generation of in-lab DNA synthesis platforms. The platform would simplify gene synthesis for researchers. Using the patented method, long DNA molecules can be assembled on-chip, and synthesis errors can be eliminated.

Synthetic genes can be produced at the molecular biology bench using common reagents and procedures, despite their easy availability. Researchers are working hard to develop long DNA molecules in the future. This is believed to assist in producing DNA sequences and proper protein production.

The surging geriatric population is expected to increase the demand for gene synthesis machines. It is crucial in treating many diseases during ageing and helps diagnose. The market has been surging with therapeutic advancements, opening new prospects for gene synthesis. The synthesis of genes and cloning are meant to reduce time and cost. These factors have led government authorities and private enterprises to invest in this technique.

Asia Pacific is expected to grab the lion’s share of the market. New opportunities for biological functionality were found in developing countries throughout the Asia Pacific region, which prompted the introduction of gene synthesis. This region continues to see a rise in geriatrics, as well as an increase in the replication of DNA. The demand for gene synthesis will continue to increase in this region as disposal incomes rise and high-quality healthcare systems expand.

Attributes Value
Gene Synthesis Market Value (2022) US$ 643.2 million
Gene Synthesis Market Expected Value (2023) US$ 779.4 million
Gene Synthesis Market Forecast Value (2033) US$ 4.5 billion
Gene Synthesis Market Expected CAGR (2023 to 2033) 19.2%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Historical CAGR (2017 to 2022) vs Anticipated CAGR: Numbers Deciphered

The massive expansion of biotechnology and gene research analysis, in particular, has opened new venues for research. With scientists conducting in-depth research on DNA sequences to study the evolution of human beings, the adoption of gene synthesis is expected to surge.

This method is also used in the current research works, which are based on increasing the lifespan of human beings. With so much significance, the market has been displaying robust growth. However, the market might witness a little slump owing to the lockdown and supply chain disruption. While the historical CAGR for the market was 19.9%, the anticipated CAGR is 19.2%.

  • Short Term (2023 to 2026): The application of gene synthesis is expected to surge in synthetic biology. This might be used for synthesizing a gene without needing an initial template in vitro laboratory settings. That would certainly enable the creation and alteration of genetic sequences at an unprecedented pace.
  • Medium Term (2026 to 2029): We might witness the method being adopted mainly by biologists during this time frame. Bioengineers and biologists might prefer gene synthesis over DNA replication because of low cost, which favors market growth.
  • Long Term (2029 to 2033): The market might experience new scope for gene synthesis in this period. There might be increased usage of gene synthesis in various fields of recombinant DNA technology, such as molecular engineering, gene therapy, and heterologous gene expression.

Gene Synthesis in Healthcare Sector: Growth Prospects

CRISPR-based therapeutics can be adapted in near-limitless ways using a new gene editing platform developed by Northwestern University researchers.

After the onset of the COVID-19 pandemic, significant companies have invested in vaccine development in response to the ongoing pandemic. As a result, gene synthesis markets using vaccine development-based gene synthesis are expected to show positive growth opportunities soon.

Chemotherapy and immunotherapy combined with targeted therapy will grow considerably in the coming years. This would create lucrative opportunities for both established and emerging companies in the healthcare sector. In addition, the focus on molecular-level research will boost demand for gene synthesis over the next few years as clinical research is intensified. In the near future, synthetic biology may enable the design of microorganisms that are capable of finding cancer cells. Microbes designed for this purpose could secrete toxic proteins that could kill cancer cells with minimal side effects and with precision.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

How will the Demand for High Accuracy Diagnostics Test affect Gene Synthesis Market?

Ongoing developments in synthetic DNA technology are gaining popularity as a viable measure to address concerns about the rising pathogens is expected to drive the market growth.

Emergence of novel strains of COVID-19 and growing penetration of targeted therapy are propelling the demand for gene synthesis to assist in characterizing genes. Also, numerous research and development institutes are increasingly adopting gene synthesis techniques to develop highly accurate diagnostics for novel diseases.

For instance, the National Institute of Standards and Technology has announced adopting gene synthesis techniques for producing new synthetic gene fragments from the COVID-19 virus. This would assist the medical testing providers in developing more accurate and reliable diagnostic tests for the disease. A slew of such developments is estimated to favor the growth in the market.

Will Medical Research and Development Activities Elevate the Market Growth?

Medical research and academic institutes are supported by strong technological and scientific expertise. They are increasingly focusing on advanced basic research activities, including applied research and synthetic biology, especially when governments prefer cost-effective approaches to conducting development projects.

With a growing demand for advanced recombinant DNA technologies, leading players in the market are extensively aiming at mergers, collaborations, and acquisitions to expand their market. For example, Eurofins Scientific, a leading testing laboratory company, announced the acquisition of a United States-based biotechnology company to expand its gene synthesis capabilities in August 2019. Hence, increasing research and development activities for novel therapeutics and diagnostics development is expected to augment the growth in the market.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Comparative View for Gene Synthesis Market

Gene Synthesis Market:

Attributes Gene Synthesis Market
Anticipated CAGR (2023 to 2033) 19.2%
Market Value (2023) US$ 779.4 million
Growth Factor Increased application of life science research
Future Opportunities Surging usage of gene editing technology
Market Trends Massive investment in research and development

Gene Editing Tools Market:

Attributes Gene Editing Tools Market
Anticipated CAGR (2023 to 2033) 20%
Market Value (2023) US$ 576 million
Growth Factor Technological advancements in genome engineering tools
Future Opportunities Increasing availability of genetically modified crops
Market Trends Application of biologics using gene editing tools

Gene Therapy Market:

Attributes Gene Therapy Market
Anticipated CAGR (2023 to 2033) 23%
Market Value (2023) US$ 8.64 billion
Growth Factor Increasing amount of people suffering from chronic diseases
Future Opportunities Massive government investments, especially for cancer treatment
Market Trends Increase in application of antigens driving growth

Country-wise Insights

Region North America
Country United States
CAGR (2023 to 2033) 15.7%
Region Europe
Country United Kingdom
CAGR (2023 to 2033) 21.4%
Region Asia Pacific
Country China
CAGR (2023 to 2033) 29.2%
Region Asia Pacific
Country Japan
CAGR (2023 to 2033) 24.1%
Region Asia Pacific
Country South Korea
CAGR (2023 to 2033) 21.6%

What are the factors facilitating the United States Gene Synthesis Market growth?

Rising implementation by drug and diagnostic developers to fuel the gene synthesis demand

As per FMI, the United States is projected to remain a dominant market for gene synthesis in North America between 2023 and 2033.

Attributes Details
United States Market Expected Size (2033) US$ 1.3 billion
United States Market Absolute Dollar Growth US$ 965.8 million
CAGR % 2017 to 2022 17.6%

Rising implementation of gene editing and synthesis-related procedures by drug and diagnostic developers in the United States is facilitating the demand for gene synthesis. Growing commercialization of synthetic gene products and increasing authorization by regulatory bodies, like the United States Food and Drug Administration, is anticipated to favor growth. Driven by this, North America is anticipated to create an incremental opportunity of more than half a billion by 2033.

Why is the United Kingdom Market Expanding at a Rapid Pace?

Increasing adoption of molecular engineering to bolster gene synthesis sales

FMI states that the United Kingdom is estimated to emerge as a highly remunerative gene synthesis market in Europe over the assessment period.

Numerous research and development startups in the United Kingdom are pursuing the potential of enzymatic synthesis and shifting their preference towards adopting gene synthesis. Gene synthesis offers higher efficiency and rapid method as compared to traditional chemical means.

Attributes Details
United Kingdom Market Expected Size (2033) US$ 241.2 million
United Kingdom Market Absolute Dollar Growth US$ 206.4 million
CAGR % 2017 to 2022 25.8%

It is extensively being used for synthesizing longer DNA sequences and molecular engineering, which is, in turn, propelling the demand for gene synthesis in the market. In addition, several well-established service laboratories and increasing developments in synthetic biology are expected to facilitate growth in the United Kingdom market.

China: Massive Development in Genomics to drive the market

In China, massive developments are happening in the field of genomics. The researchers are focusing on the development of Next Generation Sequencing, which is expected to significantly impact cellular. Direct Genomics, which is a Chinese firm, makes use of single-molecule targeted sequencing to read DNA and RNA. More such developments are expected to increase the application of gene synthesis.

Attributes Details
China Market Expected Size (2033) US$ 905.3 million
China Market Absolute Dollar Growth US$ 835.4 million
CAGR % 2017 to 2022 28.5%

China has been witnessing a rapid increase in the adoption of genetic testing. Massive surge in people suffering from chronic diseases has risen the usage of genetic testing. Spur in the availability of direct-to-consumer tests has further propelled the demand for genetic testing. Genetic testing makes use of gene synthesis to identify the nature of the molecule associated with the pathogen.

Why is the Market Flourishing in Japan?

Increasing focus on novel therapeutics development to augment the sales of gene synthesis service

With growing emphasis on novel therapeutics development, a substantial rise in demand for technologies such as gene synthesis is being observed across various fields. This is particularly observed in recombinant DNA technology, including vaccine development, gene therapy, molecular engineering, and others.

Attributes Details
Japan Market Expected Size (2033) US$ 477.6 million
Japan Market Absolute Dollar Growth US$ 422.6 million
CAGR % 2017 to 2022 25.4%

Key players are focusing on collaborating with other companies to provide gene synthesis services to expand their market share. For instance, in 2020, Takeda, a Japan-based pharmaceutical company, announced collaborating with a United States-based protein engineering company, Codexis. The partnership focused on providing gene synthesis services to the latter company for developing novel gene therapies for rare genetic disorders. An assortment of such development is estimated to spur sales in the Japan market.

South Korea: Manufacturers work on Base Editing Technology

The key players in South Korea are conducting in-depth research on base editing technology. They are using adenine base editors because of their hyper-compact gene editing technology. These are characterized by compactness in size, which can be delivered using an adeno-associated virus. These are known to have specific and versatile base editing activities. The base editing technology is known to make use of gene synthesis to study the structure of DNA and RNA.

Attributes Details
South Korea Market Expected Size (2033) US$ 154.8 million
South Korea Market Absolute Dollar Growth US$ 132.9 million
CAGR % 2017 to 2022 21.2%

The South Korean government is also making massive investments in the biotechnology market. The government announced an allocation of US$ 303 million to secure key technologies in the area of biotechnology. This represents massive opportunities for the gene synthesis market.

Category-wise Insights

Segment Service Type
Attributes Gene Synthesis Service
CAGR (2017 to 2022) 18.3%
CAGR (2023 to 2033) 16.5%
Segment Application
Attributes Research and Development Activities
CAGR (2017 to 2022) 19.6%
CAGR (2023 to 2033) 18.4%

Which Service Segment would account for Dominant Share in the Market?

Increasing standard and custom gene synthesis applications will favor market growth

FMI revealed that the gene synthesis segment is estimated to exhibit rapid growth in the market, accounting for nearly 75% of the gene synthesis sales by the end of 2033.

Within the segment, custom gene synthesis services are estimated to lead the way, owing to increasing applications across immunology, cancer research, antibody discovery, and others. Apart from this, the guanosine monophosphate (GMP) gene synthesis segment is estimated to account for a significant share.

Why are the Sales of Gene Synthesis rising in the Research and Development segment?

Growing demand for advanced synthetic biology services to augment the growth of the Research and Development segment

As per FMI, the research and development segment is estimated to hold a significant market share, accounting for more than 35% of the gene synthesis demand by 2033.

Demand for cost-effective and advanced synthetic biology services for double-stranded DNA molecule synthesis is expected to surge the segment's share. Synthetic DNA and RNA genome sequencing, heterologous gene expression, and others are widely used in research and development. Massive investments by governments worldwide in various research projects are also expected to drive market growth.

Start-ups look to Scale Up Gene Manufacturing Technology

The start-ups are developing technologies to scale up the production of gene manufacturing technology. For example, they employ a specifically engineered enzyme to enable robust and scalable DNA synthesis. That would allow the one-step generation of long, high-fidelity DNA fragments without limiting the maximum length.

Camena Bioscience: The United States-based start-up enables precise nucleic acid synthesis. The enzymatic de novo synthesis and gene assembly solution developed by the start-up produces long and complex DNA molecules with high accuracy. The technology goes by the name gSynth. It also allows synthetic biology companies to manufacture precise gene variant libraries for protein engineering.

Key Players assist Gene Therapy Companies leverage their Capabilities

The companies operating in the gene synthesis market are expanding their single-guide RNA manufacturing capabilities. This would certainly enable next-generation gene and cell therapy research and development programs to advance their clinical trials. In December 2022, cell and gene therapy companies leveraged GenScript’s cGMP and sgRNA capability to accelerate speed.

Key developments in the market are:

  • In September 2022, GenScript and Avectas collaborated to improve the non-viral cell therapy manufacturing process.
  • In January 2023, Twist Bioscience and Astellas entered into a multitarget antibody discovery research collaboration.

Leading Market Players

Company Description
Twist Bioscience Twist Bioscience has been working in the service of customers who are changing the world for better. By using the DNA synthetic tools in medicine, agriculture, industrial chemicals, and data storage, the company is looking for ways to drive better lives and sustainability in the planet. The innovative method of DNA production adopted by the company allows in the manufacturing of high-quality synthetic DNA. Twist sets the bar in product quality, meaning the product constantly meets specifications.
GenScript GenScript Biotech Corporation is the world’s leading technology and service provider of life science research and development, and manufacture. The company was founded in New Jersey in 2002, and listed on the Hong Kong Stock Exchange in 2015. GenScript’s business operations span over 100 countries and regions. The company has been providing premium, convenient, and reliable services and products to over 200,000 customers. Driven by the mission, ‘make people and nature healthier through biotechnology’, the company strives to become the most trustworthy biotech firm.
ProteoGenix ProteoGenix was started in 2003 to develop diagnostic assays and biotherapeutics to target proteins discovered by its proteins. The company realized the incredible value of high-quality antibodies and proteins for developing biopharma products. As a service integrator, the ProteoGenix guides its customers from early discovery to the clinic. The main objective of the company is to anticipate future requirements of the biomolecules from the beginning and to subsequently design a sustainable development strategy.

Other significant gene synthesis companies profiled: Brooks Automation, Inc., Boster Biological Technology

Gene Synthesis Market Segmentation

By Service:

  • Gene Synthesis Service (Standard Gene Service, Express Gene Service, Complex Gene Service, Custom Gene Synthesis Service)
  • Gene Fragments Service
  • GMP Gene Synthesis
  • Others

By Application:

  • Diagnostics
  • Therapeutics
  • Research and Development Activities
  • Others

By End User:

  • Academic and Research Institutes
  • Biotechnology Companies
  • Pharmaceutical Companies
  • Contract Research Organization

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • The Middle East and Africa

Frequently Asked Questions

Which Service Segment holds Lucrative Opportunities?

The gene synthesis service holds high revenue potential.

Which Countries Dominate the Gene Synthesis Market?

The United States, the United Kingdom, Japan and China are estimated to dominate the global market.

What is the Growth Forecast for Gene Synthesis Market?

The market is forecast to register a CAGR of 19.2% through 2033.

How is the Historical Performance of the Gene Synthesis Market?

During 2018 to 2022, the market registered a CAGR of 19.9%.

Which is the Top Trend in the Gene Synthesis Market?

The growing innovations in product services are increasing current market trends.

Table of Content

1. Executive Summary | Gene Synthesis Market

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2017 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2022

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Service Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Service Type, 2017 to 2022

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Service Type, 2023 to 2033

        5.3.1. Service

            5.3.1.1. Standard Gene Service

            5.3.1.2. Express Gene Service

            5.3.1.3. Complex Gene Service

            5.3.1.4. Custom Service

        5.3.2. Gene Fragments Service

        5.3.3. GMP Gene Synthesis

        5.3.4. Others

    5.4. Y-o-Y Growth Trend Analysis By Service Type, 2017 to 2022

    5.5. Absolute $ Opportunity Analysis By Service Type, 2023 to 2033

6. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Application

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By Application, 2017 to 2022

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2023 to 2033

        6.3.1. Diagnostics

        6.3.2. Therapeutics

        6.3.3. Reseach and Development Activities

        6.3.4. Other Application

    6.4. Y-o-Y Growth Trend Analysis By Application, 2017 to 2022

    6.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033

7. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User 

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Million) Analysis By End User , 2017 to 2022

    7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User , 2023 to 2033

        7.3.1. Academic and Research Institutes

        7.3.2. Biotechnology Companies

        7.3.3. Pharmaceutical Companies

        7.3.4. Contract Research Organisation

    7.4. Y-o-Y Growth Trend Analysis By End User , 2017 to 2022

    7.5. Absolute $ Opportunity Analysis By End User , 2023 to 2033

8. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region

    8.1. Introduction

    8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2022

    8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Europe

        8.3.4. East Asia

        8.3.5. South Asia

        8.3.6. Oceania

        8.3.7. Middle East and Africa

    8.4. Market Attractiveness Analysis By Region

9. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022

    9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        9.2.1. By Country

            9.2.1.1. USA

            9.2.1.2. Canada

        9.2.2. By Service Type

        9.2.3. By Application

        9.2.4. By End User

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Service Type

        9.3.3. By Application

        9.3.4. By End User

    9.4. Key Takeaways

10. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022

    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. Mexico

            10.2.1.2. Brazil

            10.2.1.3. Argentina

            10.2.1.4. Rest of Latin America

        10.2.2. By Service Type

        10.2.3. By Application

        10.2.4. By End User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Service Type

        10.3.3. By Application

        10.3.4. By End User

    10.4. Key Takeaways

11. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. United Kingdom

            11.2.1.2. Germany

            11.2.1.3. France

            11.2.1.4. Spain

            11.2.1.5. Italy

            11.2.1.6. Russia

            11.2.1.7. BENELUX

            11.2.1.8. Rest of Europe

        11.2.2. By Service Type

        11.2.3. By Application

        11.2.4. By End User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Service Type

        11.3.3. By Application

        11.3.4. By End User

    11.4. Key Takeaways

12. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. China

            12.2.1.2. Japan

            12.2.1.3. South Korea

        12.2.2. By Service Type

        12.2.3. By Application

        12.2.4. By End User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Service Type

        12.3.3. By Application

        12.3.4. By End User

    12.4. Key Takeaways

13. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022

    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. Thailand

            13.2.1.2. Malaysia

            13.2.1.3. India

            13.2.1.4. Indonesia

            13.2.1.5. Rest of South Asia

        13.2.2. By Service Type

        13.2.3. By Application

        13.2.4. By End User

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Service Type

        13.3.3. By Application

        13.3.4. By End User

    13.4. Key Takeaways

14. Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022

    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

            14.2.1.1. Australia

            14.2.1.2. New Zealand

        14.2.2. By Service Type

        14.2.3. By Application

        14.2.4. By End User

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Service Type

        14.3.3. By Application

        14.3.4. By End User

    14.4. Key Takeaways

15. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022

    15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        15.2.1. By Country

            15.2.1.1. GCC Countries

            15.2.1.2. South Africa

            15.2.1.3. Türkiye

            15.2.1.4. Northern Africa

            15.2.1.5. Rest of Middle East and Africa

        15.2.2. By Service Type

        15.2.3. By Application

        15.2.4. By End User

    15.3. Market Attractiveness Analysis

        15.3.1. By Country

        15.3.2. By Service Type

        15.3.3. By Application

        15.3.4. By End User

    15.4. Key Takeaways

16. Key Countries Market Analysis

    16.1. USA

        16.1.1. Pricing Analysis

        16.1.2. Market Share Analysis, 2022

            16.1.2.1. By Service Type

            16.1.2.2. By Application

            16.1.2.3. By End User

    16.2. Canada

        16.2.1. Pricing Analysis

        16.2.2. Market Share Analysis, 2022

            16.2.2.1. By Service Type

            16.2.2.2. By Application

            16.2.2.3. By End User

    16.3. Mexico

        16.3.1. Pricing Analysis

        16.3.2. Market Share Analysis, 2022

            16.3.2.1. By Service Type

            16.3.2.2. By Application

            16.3.2.3. By End User

    16.4. Brazil

        16.4.1. Pricing Analysis

        16.4.2. Market Share Analysis, 2022

            16.4.2.1. By Service Type

            16.4.2.2. By Application

            16.4.2.3. By End User

    16.5. Argentina

        16.5.1. Pricing Analysis

        16.5.2. Market Share Analysis, 2022

            16.5.2.1. By Service Type

            16.5.2.2. By Application

            16.5.2.3. By End User

    16.6. United Kingdom

        16.6.1. Pricing Analysis

        16.6.2. Market Share Analysis, 2022

            16.6.2.1. By Service Type

            16.6.2.2. By Application

            16.6.2.3. By End User

    16.7. Germany

        16.7.1. Pricing Analysis

        16.7.2. Market Share Analysis, 2022

            16.7.2.1. By Service Type

            16.7.2.2. By Application

            16.7.2.3. By End User

    16.8. France

        16.8.1. Pricing Analysis

        16.8.2. Market Share Analysis, 2022

            16.8.2.1. By Service Type

            16.8.2.2. By Application

            16.8.2.3. By End User

    16.9. Spain

        16.9.1. Pricing Analysis

        16.9.2. Market Share Analysis, 2022

            16.9.2.1. By Service Type

            16.9.2.2. By Application

            16.9.2.3. By End User

    16.10. Italy

        16.10.1. Pricing Analysis

        16.10.2. Market Share Analysis, 2022

            16.10.2.1. By Service Type

            16.10.2.2. By Application

            16.10.2.3. By End User

    16.11. Russia

        16.11.1. Pricing Analysis

        16.11.2. Market Share Analysis, 2022

            16.11.2.1. By Service Type

            16.11.2.2. By Application

            16.11.2.3. By End User

    16.12. BENELUX

        16.12.1. Pricing Analysis

        16.12.2. Market Share Analysis, 2022

            16.12.2.1. By Service Type

            16.12.2.2. By Application

            16.12.2.3. By End User

    16.13. China

        16.13.1. Pricing Analysis

        16.13.2. Market Share Analysis, 2022

            16.13.2.1. By Service Type

            16.13.2.2. By Application

            16.13.2.3. By End User

    16.14. Japan

        16.14.1. Pricing Analysis

        16.14.2. Market Share Analysis, 2022

            16.14.2.1. By Service Type

            16.14.2.2. By Application

            16.14.2.3. By End User

    16.15. South Korea

        16.15.1. Pricing Analysis

        16.15.2. Market Share Analysis, 2022

            16.15.2.1. By Service Type

            16.15.2.2. By Application

            16.15.2.3. By End User

    16.16. Thailand

        16.16.1. Pricing Analysis

        16.16.2. Market Share Analysis, 2022

            16.16.2.1. By Service Type

            16.16.2.2. By Application

            16.16.2.3. By End User

    16.17. Malaysia

        16.17.1. Pricing Analysis

        16.17.2. Market Share Analysis, 2022

            16.17.2.1. By Service Type

            16.17.2.2. By Application

            16.17.2.3. By End User

    16.18. India

        16.18.1. Pricing Analysis

        16.18.2. Market Share Analysis, 2022

            16.18.2.1. By Service Type

            16.18.2.2. By Application

            16.18.2.3. By End User

    16.19. Indonesia

        16.19.1. Pricing Analysis

        16.19.2. Market Share Analysis, 2022

            16.19.2.1. By Service Type

            16.19.2.2. By Application

            16.19.2.3. By End User

    16.20. Australia

        16.20.1. Pricing Analysis

        16.20.2. Market Share Analysis, 2022

            16.20.2.1. By Service Type

            16.20.2.2. By Application

            16.20.2.3. By End User

    16.21. New Zealand

        16.21.1. Pricing Analysis

        16.21.2. Market Share Analysis, 2022

            16.21.2.1. By Service Type

            16.21.2.2. By Application

            16.21.2.3. By End User

    16.22. GCC Countries

        16.22.1. Pricing Analysis

        16.22.2. Market Share Analysis, 2022

            16.22.2.1. By Service Type

            16.22.2.2. By Application

            16.22.2.3. By End User

    16.23. South Africa

        16.23.1. Pricing Analysis

        16.23.2. Market Share Analysis, 2022

            16.23.2.1. By Service Type

            16.23.2.2. By Application

            16.23.2.3. By End User

    16.24. Türkiye

        16.24.1. Pricing Analysis

        16.24.2. Market Share Analysis, 2022

            16.24.2.1. By Service Type

            16.24.2.2. By Application

            16.24.2.3. By End User

    16.25. Northern Africa

        16.25.1. Pricing Analysis

        16.25.2. Market Share Analysis, 2022

            16.25.2.1. By Service Type

            16.25.2.2. By Application

            16.25.2.3. By End User

17. Market Structure Analysis

    17.1. Competition Dashboard

    17.2. Competition Benchmarking

    17.3. Market Share Analysis of Top Players

        17.3.1. By Regional

        17.3.2. By Service Type

        17.3.3. By Application

        17.3.4. By End User

18. Competition Analysis

    18.1. Competition Deep Dive

        18.1.1. GenScript

            18.1.1.1. Overview

            18.1.1.2. Product Portfolio

            18.1.1.3. Profitability by Market Segments

            18.1.1.4. Sales Footprint

            18.1.1.5. Strategy Overview

                18.1.1.5.1. Marketing Strategy

        18.1.2. Brooks Automation, Inc.

            18.1.2.1. Overview

            18.1.2.2. Product Portfolio

            18.1.2.3. Profitability by Market Segments

            18.1.2.4. Sales Footprint

            18.1.2.5. Strategy Overview

                18.1.2.5.1. Marketing Strategy

        18.1.3. Boster Biological Technology

            18.1.3.1. Overview

            18.1.3.2. Product Portfolio

            18.1.3.3. Profitability by Market Segments

            18.1.3.4. Sales Footprint

            18.1.3.5. Strategy Overview

                18.1.3.5.1. Marketing Strategy

        18.1.4. Twist Bioscience

            18.1.4.1. Overview

            18.1.4.2. Product Portfolio

            18.1.4.3. Profitability by Market Segments

            18.1.4.4. Sales Footprint

            18.1.4.5. Strategy Overview

                18.1.4.5.1. Marketing Strategy

        18.1.5. ProteoGenix

            18.1.5.1. Overview

            18.1.5.2. Product Portfolio

            18.1.5.3. Profitability by Market Segments

            18.1.5.4. Sales Footprint

            18.1.5.5. Strategy Overview

                18.1.5.5.1. Marketing Strategy

        18.1.6. Biomatik

            18.1.6.1. Overview

            18.1.6.2. Product Portfolio

            18.1.6.3. Profitability by Market Segments

            18.1.6.4. Sales Footprint

            18.1.6.5. Strategy Overview

                18.1.6.5.1. Marketing Strategy

        18.1.7. Eurofins Scientific

            18.1.7.1. Overview

            18.1.7.2. Product Portfolio

            18.1.7.3. Profitability by Market Segments

            18.1.7.4. Sales Footprint

            18.1.7.5. Strategy Overview

                18.1.7.5.1. Marketing Strategy

        18.1.8. ProMab Biotechnologies, Inc.

            18.1.8.1. Overview

            18.1.8.2. Product Portfolio

            18.1.8.3. Profitability by Market Segments

            18.1.8.4. Sales Footprint

            18.1.8.5. Strategy Overview

                18.1.8.5.1. Marketing Strategy

        18.1.9. Thermo Fisher Scientific, Inc.

            18.1.9.1. Overview

            18.1.9.2. Product Portfolio

            18.1.9.3. Profitability by Market Segments

            18.1.9.4. Sales Footprint

            18.1.9.5. Strategy Overview

                18.1.9.5.1. Marketing Strategy

        18.1.10. Integrated DNA Technologies, Inc.

            18.1.10.1. Overview

            18.1.10.2. Product Portfolio

            18.1.10.3. Profitability by Market Segments

            18.1.10.4. Sales Footprint

            18.1.10.5. Strategy Overview

                18.1.10.5.1. Marketing Strategy

        18.1.11. OriGene Technologies, Inc.

            18.1.11.1. Overview

            18.1.11.2. Product Portfolio

            18.1.11.3. Profitability by Market Segments

            18.1.11.4. Sales Footprint

            18.1.11.5. Strategy Overview

                18.1.11.5.1. Marketing Strategy

19. Assumptions & Acronyms Used

20. Research Methodology

Recommendations

Healthcare

Osteoarthritis Gene Therapy Market

Published : January 2023

Healthcare

Microbial Gene Editing Services Market

Published : June 2022

Explore Healthcare Insights

View Reports